share_log

Cantor Fitzgerald Reiterates Overweight on SELLAS Life Sciences Gr, Maintains $3 Price Target

Benzinga ·  Sep 8, 2023 00:00

Cantor Fitzgerald analyst Li Watsek reiterates SELLAS Life Sciences Gr (NASDAQ:SLS) with a Overweight and maintains $3 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment